Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the
1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract …

Background Seroprevalence data suggest that a third of the world's population has been
infected with the hepatitis E virus. Our aim was to assess efficacy and safety of a recombinant …

Background Timely diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection is a prerequisite for treatment and prevention. The serology characteristics …

Background Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term
efficacy of a hepatitis E vaccine needs to be determined. Methods In an initial efficacy study, we …

Tissue repair and regenerative medicine address the important medical needs to replace
damaged tissue with functional tissue. Most regenerative medicine strategies have focused on …

Background All currently available SARS-CoV-2 vaccines are administered by
intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated …

Evidence that hepatitis E is zoonotic is accumulating. Serum samples were collected from
pigs, cattle, and goats from various regions of China to determine whether they had been …

A novel hepatitis B virus (HBV) strain (W29) was isolated from serum samples in the northwest
of China. Phylogenetic and distance analyses indicate that this strain is grouped with a …

BACKGROUND & AIMS: This study aimed at investigating mutations in the hepatitis B surface
protein (HBsAg) in occult hepatitis B virus (HBV) infection (OBI) and their influence on viral …

All hepatitis E virus (HEV) variants reported to infect humans belong to the species Orthohepevirus
A (HEV-A). The zoonotic potential of the species Orthohepevirus C (HEV-C), which …